Last reviewed · How we verify
A Double-blind, Randomized Controlled Study of Low Concentration Atropine in the Prevention of Myopia in Pre-myopia Children.
This double-blind, randomized controlled clinical study is to evaluate the effectiveness and safety of low concentration atropine in preventing myopia in pre-myopia children, and to explore whether there is a dose effect relationship between different concentrations of atropine in preventing myopia.
Details
| Lead sponsor | Shanghai Eye Disease Prevention and Treatment Center |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 428 |
| Start date | 2023-04-01 |
| Completion | 2024-04 |
Conditions
- Myopia, Progressive
Interventions
- low concentration atropine (0.01%)
- low concentration atropine (0.02%)
- low concentration atropine (0.04%)
- Placebo
Primary outcomes
- Cumulative Incidence of Myopia — 1 year
Effectiveness Evaluation
Countries
China